HYBRIDON INC
10-Q, EX-27, 2000-11-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: HYBRIDON INC, 10-Q, 2000-11-14
Next: TUDOR FUND FOR EMPLOYEES LP, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                       5,236,326
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             5,281,317
<PP&E>                                       5,351,069
<DEPRECIATION>                               5,285,197
<TOTAL-ASSETS>                              11,430,298
<CURRENT-LIABILITIES>                        8,534,236
<BONDS>                                      9,274,110
                                0
                                      6,121
<COMMON>                                        17,925
<OTHER-SE>                                 (6,378,048)
<TOTAL-LIABILITY-AND-EQUITY>                11,430,298
<SALES>                                              0
<TOTAL-REVENUES>                               212,541
<CGS>                                                0
<TOTAL-COSTS>                                5,133,846
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,856,677
<INCOME-PRETAX>                            (6,777,982)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (6,777,982)
<DISCONTINUED>                               5,292,154
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,485,828)
<EPS-BASIC>                                     (0.27)
<EPS-DILUTED>                                   (0.27)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission